Zobrazeno 1 - 10
of 232
pro vyhledávání: '"Campton NA"'
Autor:
Várnai, C, Palles, C, Arnold, R, Curley, HM, Purshouse, K, Cheng, VWT, Booth, S, Campton, NA, Collins, GP, Hughes, DJ, Kulasekararaj, AG, Lee, AJX, Olsson-Brown, AC, Sharma-Oates, A, Van Hemelrijck, M, Lee, LYW, Kerr, R, Middleton, G, Cazier, J-B, UKCCMP Team
Importance Large cohorts of patients with active cancers and COVID-19 infection are needed to provide evidence of the association of recent cancer treatment and cancer type with COVID-19 mortality. Objective To evaluate whether systemic anticancer tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::3ff0a2c1612604ec79d5d24fc67d34d0
https://eprints.whiterose.ac.uk/184087/1/vrnai_2022_oi_220011_1644548912.0317.pdf
https://eprints.whiterose.ac.uk/184087/1/vrnai_2022_oi_220011_1644548912.0317.pdf
Autor:
Lee, LY, Cazier, J-B, Angelis, V, Arnold, R, Bisht, V, Campton, NA, Chackathayil, J, Cheng, VW, Curley, HM, Fittall, MW, Freeman-Mills, L, Gennatas, S, Goel, A, Hartley, S, Hughes, DJ, Kerr, D, Lee, AJ, Lee, RJ, McGrath, SE, Middleton, CP, Murugaesu, N, Newsom-Davis, T, Okines, AF, Olsson-Brown, AC, Palles, C, Pan, Y, Pettengell, R, Powles, T, Protheroe, EA, Purshouse, K, Sharma-Oates, A, Sivakumar, S, Smith, AJ, Starkey, T, Turnbull, CD, Várnai, C, Yousaf, N, Team, UK Coronavirus Monitoring Project, Kerr, R, Middleton, G
Publikováno v:
The Lancet
Purshouse, K 2020, ' COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments : a prospective cohort study ', The Lancet, vol. 395, no. 10241, pp. 1919-1926 . https://doi.org/10.1016/S0140-6736(20)31173-9
The UK Coronavirus Monitoring Project Team 2020, ' COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study ', The Lancet, vol. 395, no. 10241, pp. 1919-1926 . https://doi.org/10.1016/S0140-6736(20)31173-9
Purshouse, K 2020, ' COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments : a prospective cohort study ', The Lancet, vol. 395, no. 10241, pp. 1919-1926 . https://doi.org/10.1016/S0140-6736(20)31173-9
The UK Coronavirus Monitoring Project Team 2020, ' COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study ', The Lancet, vol. 395, no. 10241, pp. 1919-1926 . https://doi.org/10.1016/S0140-6736(20)31173-9
Background Individuals with cancer, particularly those who are receiving systemic anticancer treatments, have been postulated to be at increased risk of mortality from COVID-19. This conjecture has considerable effect on the treatment of patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7d31ab90140c0c66272b3cfafe2ca3b
Autor:
Booth S; Oxford NIHR Biomedical Research Centre, Department of Haematology, Churchill Hospital, Oxford, UK., Curley HM; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Varnai C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Arnold R; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Lee LYW; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Department of Oncology, Oxford University, Oxford, UK., Campton NA; Institute of Translational Medicine, Birmingham Health Partners, Birmingham, UK., Cook G; NIHR (Leeds) MIC, Leeds, St James's Teaching Hospital, University of Leeds, Leeds, UK., Purshouse K; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK., Aries J; Barts Health NHS Trust, London, UK., Innes A; Imperial College Healthcare NHS Trust, London, UK., Cook LB; Imperial College Healthcare NHS Trust, London, UK., Tomkins O; Leswisham and Greenwich NHS Trust, London, UK., Oram HS; Leswisham and Greenwich NHS Trust, London, UK., Tilby M; Queen Elizabeth Hospital, Birmingham, UK., Kulasekararaj A; Department of Haematology, King's College Hospital, London, UK., Wrench D; Guys and St Thomas' NHS Foundation Trust, London, UK., Dolly S; Guys and St Thomas' NHS Foundation Trust, London, UK., Newsom-Davies T; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Pettengell R; St Georges University Hospitals NHS Foundation Trust, London, UK., Gault A; NCCC Northern Centre for Cancer Care, The Newcastle Upon Tyne NHS Foundation Trust, Newcastle, UK., Moody S; NCCC Northern Centre for Cancer Care, The Newcastle Upon Tyne NHS Foundation Trust, Newcastle, UK., Mittal S; Northampton General Hospital NHS Trust, Northampton, UK., Altohami M; Northampton General Hospital NHS Trust, Northampton, UK., Tillet T; Royal United Hospitals Bath, Bath, UK., Illingworth J; Barking, Havering and Redbridge University Hospitals NHS Trust, Essex, UK., Mukherjee L; Beatson West of Scotland Cancer Centre, Glasgow, UK., Apperly J; Imperial College Healthcare NHS Trust, London, UK., Ashcroft J; NIHR (Leeds) MIC, Leeds, St James's Teaching Hospital, University of Leeds, Leeds, UK.; Mid Yorkshire Hospitals NHS Trust, Wakefield, UK., Rabin N; University College London Hospitals, London, UK., Carmichael J; NIHR (Leeds) MIC, Leeds, St James's Teaching Hospital, University of Leeds, Leeds, UK., Cazier JB; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Kerr R; Department of Oncology, Oxford University, Oxford, UK., Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, UK., Collins GP; Oxford NIHR Biomedical Research Centre, Department of Haematology, Churchill Hospital, Oxford, UK., Palles C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Publikováno v:
British journal of haematology [Br J Haematol] 2022 Feb; Vol. 196 (4), pp. 892-901. Date of Electronic Publication: 2021 Nov 10.
Autor:
Várnai C; Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Cancer Research UK Birmingham Centre, University of Birmingham, United Kingdom., Palles C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Arnold R; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Curley HM; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Purshouse K; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, United Kingdom., Cheng VWT; Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom., Booth S; Oxford NIHR Biomedical Research Centre, Department of Haematology, Churchill Hospital, Oxford, United Kingdom., Campton NA; Institute of Translational Medicine, Birmingham Health Partners, Birmingham, United Kingdom., Collins GP; Oxford NIHR Biomedical Research Centre, Department of Haematology, Churchill Hospital, Oxford, United Kingdom., Hughes DJ; Department of Cancer Imaging, King's College London, London, United Kingdom., Kulasekararaj AG; Department of Haematology, King's College Hospital, London, United Kingdom., Lee AJX; UCL Cancer Institute, University College London, London, United Kingdom., Olsson-Brown AC; The Clatterbridge Cancer Centre, Wirral, United Kingdom.; The University of Liverpool, Liverpool, United Kingdom., Sharma-Oates A; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom., Van Hemelrijck M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Lee LYW; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Department of Oncology, Oxford University, Oxford, United Kingdom., Kerr R; Department of Oncology, Oxford University, Oxford, United Kingdom., Middleton G; Cancer Research UK Birmingham Centre, University of Birmingham, United Kingdom.; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, United Kingdom.; Queen Elizabeth Hospital, Birmingham, United Kingdom., Cazier JB; Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Cancer Research UK Birmingham Centre, University of Birmingham, United Kingdom.; Queen Elizabeth Hospital, Birmingham, United Kingdom.
Publikováno v:
JAMA network open [JAMA Netw Open] 2022 Feb 01; Vol. 5 (2), pp. e220130. Date of Electronic Publication: 2022 Feb 01.
Autor:
Chen, Xin1 (AUTHOR), Jiang, Baohong2 (AUTHOR), Gu, Yu1 (AUTHOR), Yue, Zhaoyang1 (AUTHOR), Liu, Ying1 (AUTHOR), Lei, Zhiwei1,3 (AUTHOR), Yang, Ge4,5 (AUTHOR), Deng, Minhua6 (AUTHOR), Zhang, Xuelong1 (AUTHOR), Luo, Zhen1 (AUTHOR), Li, Yongkui1 (AUTHOR), Zhang, Qiwei1 (AUTHOR), Zhang, Xuepei7 (AUTHOR), Wu, Jianguo1 (AUTHOR), Huang, Chunyu6,8 (AUTHOR) huangchy@sysucc.org.cn, Pan, Pan9,10 (AUTHOR) panpan@jnu.edu.cn, Zhou, Fangjian6 (AUTHOR) zhoufj@sysucc.org.cn, Wang, Ning6,7 (AUTHOR) wangning07011992@163.com
Publikováno v:
Molecular Cancer. 11/6/2024, Vol. 23 Issue 1, p1-18. 18p.
Autor:
Chewaskulyong, Busyamas1 (AUTHOR), Satjaritanun, Pattarapong1 (AUTHOR), Ketpueak, Thanika1 (AUTHOR), Suksombooncharoen, Thatthan1 (AUTHOR), Charoentum, Chaiyut1 (AUTHOR), Nuchpong, Nuttaphoom2 (AUTHOR), Tantraworasin, Apichat3 (AUTHOR) Apichat.t@cmu.ac.th
Publikováno v:
PLoS ONE. 11/7/2024, Vol. 19 Issue 11, p1-17. 17p.
Autor:
Jiang, Jiaxin1 (AUTHOR), Meng, Xiaona2 (AUTHOR), Wang, Yibo3 (AUTHOR), Zhuang, Ziqian3 (AUTHOR), Du, Ting4 (AUTHOR), Yan, Jing1 (AUTHOR) jyan@cmu.edu.cn
Publikováno v:
PLoS Computational Biology. 9/27/2024, Vol. 20 Issue 9, p1-28. 28p.
Autor:
Jaiswal, Aishwarya1 (AUTHOR), Shrivastav, Sanah2 (AUTHOR), Kushwaha, Hemant R.3,4 (AUTHOR), Chaturvedi, Rupesh3,4 (AUTHOR), Singh, Rana P.1,4,5 (AUTHOR) rana_singh@mail.jnu.ac.in
Publikováno v:
Cell Communication & Signaling. 9/26/2024, Vol. 22 Issue 1, p1-23. 23p.
Autor:
Seyyedsalehi, Monireh Sadat1,2 (AUTHOR), Rahmati, Marveh3 (AUTHOR), Ghalehtaki, Reza4,5 (AUTHOR), Nahvijou, Azin1 (AUTHOR), Eslami, Bita6 (AUTHOR), Shaka, Zoha1 (AUTHOR), Allameh, Seyed Farshad7 (AUTHOR), Zendehdel, Kazem1 (AUTHOR) kzendeh@tums.ac.ir
Publikováno v:
BMC Cancer. 9/3/2024, Vol. 24 Issue 1, p1-11. 11p.
Autor:
Lee LYW; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Department of Oncology, University of Oxford, Oxford, UK; University Hospitals Birmingham, Birmingham, UK., Cazier JB; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Starkey T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Briggs SEW; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Arnold R; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Bisht V; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Booth S; Department of Haematology, University of Oxford, Oxford, UK., Campton NA; Institute of Translational Medicine, Birmingham Health Partners, Birmingham, UK., Cheng VWT; Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Collins G; Department of Haematology, University of Oxford, Oxford, UK., Curley HM; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Earwaker P; University Hospitals Birmingham, Birmingham, UK., Fittall MW; The Royal Marsden Hospital NHS Foundation Trust, London, UK., Gennatas S; The Royal Marsden Hospital NHS Foundation Trust, London, UK., Goel A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Hartley S; Centre for Computational Biology, University of Birmingham, Birmingham, UK; Advanced Research Computing, University of Birmingham, Birmingham, UK., Hughes DJ; Department of Cancer Imaging, King's College London, London, UK., Kerr D; Nuffield Division of Clinical and Laboratory Services, University of Oxford, Oxford, UK., Lee AJX; UCL Cancer Institute, University College London, London, UK., Lee RJ; The University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK., Lee SM; University College London, London, UK., Mckenzie H; University Hospital Southampton, UK., Middleton CP; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Murugaesu N; St George's University Hospitals NHS Foundation Trust, London, UK., Newsom-Davis T; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Olsson-Brown AC; The Clatterbridge Cancer Centre, Birkenhead, UK., Palles C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Powles T; Bart's Cancer Institute, London, UK., Protheroe EA; University of Birmingham Medical School, University of Birmingham, Birmingham, UK., Purshouse K; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK., Sharma-Oates A; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK., Sivakumar S; Department of Oncology, University of Oxford, Oxford, UK., Smith AJ; Consultancy Support, Oxford, UK., Topping O; University Hospitals Birmingham, Birmingham, UK., Turnbull CD; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Várnai C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Briggs ADM; Warwick Medical School, University of Warwick, Coventry, UK., Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; University Hospitals Birmingham, Birmingham, UK. Electronic address: g.middleton@bham.ac.uk., Kerr R; Department of Oncology, University of Oxford, Oxford, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2020 Oct; Vol. 21 (10), pp. 1309-1316. Date of Electronic Publication: 2020 Aug 24.